CN Patent

CN115124514A — Kd-025的共晶及其制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2022-09-30 · 4y expired

What this patent protects

本发明涉及KD‑025的共晶及其制备方法，属于医药化工技术领域。本发明提供的KD‑025的共晶具有稳定性好、不易受溶剂影响等优点；所述制备方法简单，操作方便，条件温和，适合工业化生产。

USPTO Abstract

本发明涉及KD‑025的共晶及其制备方法，属于医药化工技术领域。本发明提供的KD‑025的共晶具有稳定性好、不易受溶剂影响等优点；所述制备方法简单，操作方便，条件温和，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN115124514A
Jurisdiction
CN
Classification
—
Expires
2022-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.